Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025

Supplementary Figure 2 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BTBianca TesiARAnna RobeliusBBBerivan Baskin

Discussion

Loading...

Member takes

Overview

Prospective cohort study shows diagnostic yield in myeloid neoplasms with germline predisposition, highlighting CytoMol's role.

Key Points

  • The study validates guidelines for genetic investigation of myeloid neoplasms with germline predisposition.
  • Diagnostic yield was assessed based on criteria, identifying a total of 39 patients fulfilling CytoMol criteria.
  • Inclusion in the study was based on multiple criteria including medical and family history.
  • Results indicate that understanding variants of unknown significance can improve diagnosis and treatment options.

Cite This Study

Tesi et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc6b7https://doi.org/10.1158/1078-0432.29568280
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Data from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  2. 2Supplementary Figure 4 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  3. 3Supplementary Figure 5 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  4. 4Supplementary Figure 1 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  5. 5Supplementary Figure 6 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025